Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. (Q30249670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

review article

1 reference

title

Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Alice Capogrosso Sansone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Alessandra Marino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Maria T Galiulo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Stefania Mantarro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Luca Antonioli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Marco Tuccori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

1 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

903-924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A new indication for therapeutic drug monitoring in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome: Historical perspective, current focus, future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal withdrawal syndrome: reaching epidemic proportions across the globe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Fetal and neonatal effects of maternal drug treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome: strategies for care of the drug-exposed infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal opioid withdrawal and antenatal opioid prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome after methadone or buprenorphine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

21 January 2018

Neonatal drug withdrawal

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal opiate abstinence syndrome in term and preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Periconceptional use of opioids and the risk of neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effects of maternal oral morphine consumption on neural tube development in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal treatment with opioid analgesics and risk for birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Prenatally buprenorphine-exposed children: health to 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Behavioral effects of perinatal opioid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Do maternal opioids reduce neonatal regional brain volumes? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Withdrawal syndrome in a newborn infant born to an addicted mother receiving methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Buprenorphine in pregnant opioid-dependent women: first results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal methadone treatment and neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal neurobehavior effects following buprenorphine versus methadone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal methadone dose and neonatal withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The effect of methadone dose regimen on neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Treatment of severe low back pain with opioids during pregnancy in a patient with incomplete tetraplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome due to codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal withdrawal syndrome due to maternal codeine use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome (NAS) after intrauterine exposure to tramadol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal withdrawal symptoms associated with maternal use of pentazocine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Management of neonatal abstinence syndrome in neonates born to opioid maintained women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Use of buprenorphine in pregnancy: patient management and effects on the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Opioids in pregnancy and neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Opioid neonatal abstinence syndrome: controversies and implications for practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Review of the assessment and management of neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Update on the pharmacologic management of neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Physical dependence produced by central morphine infusions: an anatomical mapping study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Opioid abuse and brain gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Pharmacologic management of the opioid neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maintenance agonist treatments for opiate-dependent pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The use of psychotropic medication during pregnancy: how about the newborn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Antidepressant use during pregnancy: current controversies and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Paroxetine use during pregnancy: is it safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Clomipramine concentration and withdrawal symptoms in 10 neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Poor neonatal adaptation after in utero exposure to duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Duloxetine withdrawal syndrome in a newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Prolonged neonatal complications after in utero exposure to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal convulsions caused by withdrawal from maternal clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Paroxetine and neonatal withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonate characteristics after maternal use of antidepressants in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Paroxetine withdrawal in a neonate with historical and laboratory confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The safety of duloxetine during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Pharmacological aspects of neonatal antidepressant withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal toxicity following maternal citalopram treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Serotonin reuptake inhibitor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Selective serotonin reuptake inhibitors in pregnancy and infant outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Serotonin syndrome in a breast-fed neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Duloxetine transfer across the placenta during pregnancy and into milk during lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Use of duloxetine in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal episodic hypoglycemia: A finding of valproic acid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Developing diagnostic criteria for the fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Antiepileptic drug use by pregnant women enrolled in Florida Medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Changing patterns of antiepileptic drug use in pregnant Australian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effects of in utero antiepileptic drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Best practice guidelines for the management of women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Fetal phenytoin exposure, hypoplastic nails, and jitteriness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Drug points: Neonatal convulsions after withdrawal of baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal seizures caused by lamotrigin withdrawal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Gender aspects of pharmacokinetics of new and old AEDs: pregnancy and breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Gabapentin withdrawal syndrome in the presence of a taper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Delirium associated with baclofen withdrawal: a review of common presentations and management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Valproic acid-induced rapid changes of met-enkephalin levels in rat brain. Probable association with abstinence behavior and anticonvulsant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Infants born to mothers under phenobarbital treatment: correlation between serum levels and clinical features of neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Barbiturate Withdrawal Syndrome in a Passively Addicted Infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal barbiturate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Letter: Withdrawal symptoms in newborn infants of epileptic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Antiepileptic drugs and breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Phenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effects of exposure to benzodiazepine during fetal life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The effects of benzodiazepine use during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The use of flumazenil in a neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A study of the plasma concentrations of lorazepam in mother and neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

"Floppy infant syndrome" and maternal diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Premedication for elective Caesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Flumazenil reverses diazepam-induced neonatal apnoea and hypotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Withdrawal symptoms in neonates from intrauterine exposure to diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Effect of diazepam administered to mothers during labour on temperature regulation of neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Diazepam in Labour: Its Metabolism and Effect on the Clinical Condition and Thermogenesis of the Newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Use of Benzodiazepines during Pregnancy, Labour and Lactation, with Particular Reference to Pharmacokinetic Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Benzodiazepine dependence. Avoidance and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Fertility of psychiatric first admissions in Norway 1936-1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Women with nonorganic psychosis: pregnancy's effect on mental health during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Family planning needs and STD risk behaviours of female psychiatric out-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Special considerations in treating bipolar disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Protective effect of pregnancy in women with lithium-responsive bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Epidemiology of puerperal psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Rates of mental disease related to childbearing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Increasing use of atypical antipsychotics and anticonvulsants during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Use and safety of antipsychotic drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Antipsychotic therapy during early and late pregnancy. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal use of antipsychotics in early pregnancy and delivery outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Prenatal antipsychotic exposure and neuromotor performance during infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Managing psychosis in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Outcome of Infants Exposed to Olanzapine During Breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

21 January 2018

Clozapine and pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Clozapine and pregnancy--a case history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Maternal clozapine treatment and decreased fetal heart rate variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Olanzapine-exposed pregnancies and lactation: early experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Withdrawal syndromes associated with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Breastfeeding and psychotropic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Clonidine: placental transfer and neonatal adaption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal seizures associated with maternal hydroxyzine hydrochloride in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Rapid-eye-movement sleep in jittery infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Clozapine and lorazepam administration in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

The Neonatal Narcotic Withdrawal Index: A Device for the Improvement of Care in the Abstinence Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-016-0435-8

Neonatal alprazolam withdrawal--possible effects of breast feeding.

21 January 2018

1 reference

12 December 2020

Valproic acid transfer across human placental cotyledon during dual perfusion in vitro

1 reference

12 December 2020

Primidone and Phenobarbital during Lactation Period in Epileptic Women: Total and Free Drug Serum Levels in the Nursed Infants and Their Effects on Neonatal Behavior

1 reference

12 December 2020

Neonatal abstinence syndrome: assessment and management

1 reference

12 December 2020

Neonatal drug withdrawal from propoxyphene

1 reference

12 December 2020

Chlordiazepoxide in labor. Its effect on the newborn infant

1 reference

12 December 2020

Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and the elimination from neonates

1 reference

12 December 2020

Antidepressant discontinuation syndrome

1 reference

12 December 2020

Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study

1 reference

12 December 2020

Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine

1 reference

12 December 2020

Is there anything new on the use of psychotropic drugs during pregnancy?

1 reference

12 December 2020

Safety of escitalopram in pregnancy: a case series

1 reference

12 December 2020

Use of baclofen for withdrawal in a preterm infant

1 reference

12 December 2020

Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs

1 reference

12 December 2020

Fluphenazine decanoate during pregnancy

1 reference

12 December 2020

Possible effect of chlordiazepoxide on the fetus

1 reference

12 December 2020

The opioid-exposed newborn: assessment and pharmacologic management

1 reference

12 December 2020

Methadone maintenance and breastfeeding in the neonatal period

1 reference

12 December 2020

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

1 reference

12 December 2020

Maternal methadone therapy increases QTc interval in newborn infants

1 reference

12 December 2020

[Buprenorphine (Subutex) and neonatal withdrawal syndrome]

1 reference

12 December 2020

Placental transfer of phenobarbitone in epileptic women, and elimination in newborns

1 reference

12 December 2020

Intrauterine effect of phenothiazines

1 reference

12 December 2020

Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study

1 reference

12 December 2020

Lorazepam premedication for labour

1 reference

12 December 2020

"Floppy infant syndrome" and maternal diazepam

1 reference

12 December 2020

Clozapine use in two full-term pregnancies

1 reference

12 December 2020

Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.

1 reference

12 December 2020

Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome.

1 reference

12 December 2020

Severe rhinorrhea and respiratory distress in a neonate exposed to fluphenazine hydrochloride prenatally

1 reference

12 December 2020

Side-effects of maternal diazepam on the newborn infant.

1 reference

12 December 2020

Side effects of treatment with benzodiazepines.

1 reference

12 December 2020

Neonatal apnea associated with maternal clonazepam therapy: a case report

1 reference

12 December 2020

Infant and maternal characteristics in neonatal abstinence syndrome--selected hospitals in Florida, 2010-2011.

1 reference

12 December 2020

A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy

1 reference

12 December 2020

Tramadol withdrawal in a neonate

1 reference

12 December 2020

Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.

1 reference

12 December 2020

Neonatal abstinence syndrome

1 reference

12 December 2020

Reversal of fetal benzodiazepine intoxication using flumazenil.

1 reference

12 December 2020

In utero oxcarbazepine and a withdrawal syndrome, anomalies, and hyponatremia

1 reference

12 December 2020

Oxazepam withdrawal in the neonatal period

1 reference

12 December 2020

Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

1 reference

12 December 2020

Strengths and limitations of the Apgar score: a critical appraisal

1 reference

12 December 2020

Letter: Transplacental passage of chlordiazepoxide

1 reference

12 December 2020

Can we use anxiolytics during pregnancy without anxiety?

1 reference

12 December 2020

Neonatal convulsions secondary to paroxetine withdrawal

1 reference

12 December 2020

The safety profile of escitalopram in pregnancy and breastfeeding

1 reference

12 December 2020

Neonatal Gabapentin Withdrawal Syndrome

1 reference

12 December 2020

Blood levels of diazepam in infants of two mothers given large doses of diazepam during labour

1 reference

12 December 2020

The impact of reproductive events on the course of bipolar disorder in women

1 reference

12 December 2020

Neonatal codeine withdrawal in infants of nonaddicted mothers

1 reference

12 December 2020

Floppy-infant syndrome: Is oxazepam the answer?

1 reference

12 December 2020

Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants

1 reference

12 December 2020

Disappearance from the newborn of circulating prenatally administered phenobarbital

1 reference

12 December 2020

The neonatal withdrawal inventory: a simplified score of newborn withdrawal

1 reference

12 December 2020

Adverse effects on newborns from intra uterine exposure to benzodiazepines and other psychotropic agents (author's transl)

1 reference

12 December 2020

Neonatal outcome following methadone exposure in utero

1 reference

12 December 2020

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

1 reference

12 December 2020

Maternal psychotropic medication and neonatal behavior

1 reference

12 December 2020

Discontinuation of Phenytoin, Carbamazepine, and Valproate in Patients with Active Epilepsy

1 reference

12 December 2020

Chlordiazepoxide withdrawal in the neonate

1 reference

12 December 2020

Diazepam (valium) during labor

1 reference

12 December 2020

Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride

1 reference

12 December 2020

Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.

1 reference

12 December 2020

Neonatal behaviour and maternal barbiturates

1 reference

12 December 2020

Letter: Pentazocine and neonatal withdrawal symptoms

1 reference

12 December 2020

The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation

1 reference

12 December 2020

Fluoxetine withdrawal syndrome in the newborn.

1 reference

12 December 2020

Diazepam (valium) as an adjunct in obstetric analgesia

1 reference

12 December 2020

["Floppy infant" syndrome in twins secondary to the use of benzodiazepines during pregnancy]

1 reference

12 December 2020

Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero

1 reference

12 December 2020

Neonatal withdrawal from propoxyphene hydrochloride

1 reference

12 December 2020

Neonatal withdrawal symptoms associated with maternal use of propoxyphene hydrochloride (Darvon)

1 reference

12 December 2020

Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy

1 reference

12 December 2020

Clonazepam and pregnancy

1 reference

12 December 2020

Floppy-infant syndrome and maternal diazepam and/or nitrazepam

1 reference

12 December 2020

First admission with puerperal psychosis: 7?14 years of follow-up

1 reference

12 December 2020

Withdrawal symptoms in the neonate from presumptive intrauterine exposure to diazepam: report of case.

1 reference

12 December 2020

A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome

1 reference

12 December 2020

Diazepam in preeclamptic toxaemia with special reference to its effect on the newborn infant

1 reference

12 December 2020

Pharmacological causes of hyperprolactinemia

1 reference

12 December 2020

Possible neonatal diazepam withdrawal: a case report

1 reference

12 December 2020

Maternal barbiturate utilization and neonatal withdrawal symptomatology

1 reference

12 December 2020

Neonatal abstinence syndrome and cerebral infarction following maternal codeine use during pregnancy

1 reference

12 December 2020

[Intranatal Administration of midazolam (author's transl)]

1 reference

12 December 2020

Neonatal pentazocine withdrawal syndrome--a case report of conservative treatment

1 reference

12 December 2020

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

1 reference

12 December 2020

Probable neonatal propoxyphene withdrawal: a case report

1 reference

12 December 2020

Neonatal withdrawal symptoms following the use of clomipramine during pregnancy

1 reference

12 December 2020

Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant

1 reference

12 December 2020

Side effects of phenobarbital in epilepsy: a systematic review

1 reference

12 December 2020

Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine

1 reference

12 December 2020

Neonatal seizures from in utero venlafaxine exposure

1 reference

12 December 2020

The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study

1 reference

12 December 2020

[Neonatal consequences of benzodiazepines used during the last month of pregnancy]

1 reference

12 December 2020

Prenatal care for pregnant chronic mentally ill patients

1 reference

12 December 2020

Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes

1 reference

12 December 2020

[Neonatal abstinence syndrome after maternal use of tramadol]

1 reference

12 December 2020

Effect of maternal lorazepam on the neonate

1 reference

12 December 2020

Neonatal seizures after use of pyridoxine in pregnancy

1 reference

12 December 2020

Narcotic withdrawal reaction in a newborn infant due to codeine

1 reference

12 December 2020

On the transfer of barbiturates to the human foetus and their accumulation in some of its vital organs

1 reference

12 December 2020

Exposure to benzodiazepines in utero

1 reference

12 December 2020

Complications during pregnancy in women with epilepsy: population-based cohort study

1 reference

12 December 2020

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome

1 reference

12 December 2020

Teratogenic determinants of first-trimester exposure to antiepileptic medications

1 reference

12 December 2020

10.1007/S40264-016-0435-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 March 2020

1050398541

0 references

Fatcat ID

release_ezixnavajvaszcubm4opkscchi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ezixnavajvaszcubm4opkscchi

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27289228%20AND%20SRC:MED&resulttype=core&format=json